NAICS 541714Research and Development in Biotechnology (except Nanobiotechnology)

The Census Bureau's definition, the SBA size standard that decides who is small under it, and the federal market behind it: what the government spends under 541714, the agencies that buy it, the companies that win it and the notices open under it today.

Not available

Federal contract obligations

FY 2022 to FY 2027 so far

Not available

Top buying department

USAspending.gov

Not available

To small businesses

Share of the obligations

18

Open notices now

SAM.gov, posted under this code

Official definition

Census Bureau, 2022 NAICS, verbatim.

This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries.

Illustrative Examples:

Cloning research and experimental development laboratories DNA technologies (e.g., microarrays) research and experimental development laboratories Nucleic acid chemistry research and experimental development laboratories Protein engineering research and experimental development laboratories Recombinant DNA research and experimental development laboratories

Illustrative activities (20)

  • Biotechnology research and development laboratories or services (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in agriculture (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in bacteriology (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in biology (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in botany (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in chemical sciences (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in entomology (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in environmental science (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in food science (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in genetics (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in industrial research (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in the medical sciences (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in the physical sciences (except nanobiotechnology research and development)
  • Biotechnology research and development laboratories or services in the veterinary sciences (except nanobiotechnology research and development)
  • Cloning research and experimental development laboratories
  • DNA technologies (e.g., microarrays) research and experimental development laboratories
  • Nucleic acid chemistry research and experimental development laboratories
  • Protein engineering research and experimental development laboratories
  • Recombinant DNA research and experimental development laboratories

What the manual classifies elsewhere

  • Conducting research and experimental development in nanotechnology (e.g., nanobiotechnology)--are classified in U.S. Industry 541713, Research and Development in Nanotechnology;541713
  • Conducting research and experimental development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)--are classified in U.S. Industry 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology);541715
  • Providing physical, chemical, or other analytical testing services (except medical or veterinary), such as acoustics or vibration testing, calibration testing, electrical and electronic testing, geotechnical testing, mechanical testing, nondestructive testing, or thermal testing--are classified in Industry 541380, Testing Laboratories and Services;541380
  • Providing veterinary testing services--are classified in Industry 541940, Veterinary Services;541940
  • Providing medical laboratory testing for humans--are classified in U.S. Industry 621511, Medical Laboratories;621511
  • Raising funds for health related research--are classified in U.S. Industry 813212, Voluntary Health Organizations;813212
  • Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing; and325414
  • Manufacturing uncompounded medicinal chemicals and their derivatives (i.e., enzyme proteins and antibiotics for pharmaceutical use)--are classified in U.S. Industry 325411, Medicinal and Botanical Manufacturing.325411

Small business size standard

SBA's rule under 13 C.F.R. 121.201, a different authority from the classification.

1,000 employees

In force today. 13 C.F.R. 121.201

SBA proposes2,800 employeesRaised 2.8x

Proposed rule, 91 FR 53741 (Aug 20, 2026). Comments closed Nov 20, 2026. Not in force until SBA publishes a final rule.

Read the comments on Regulations.gov

Docket SBA-2026-0199

SBA OHA appeals that cite it

NAICS designation and size appeals whose caption or digest states this code. OHA dockets by case number rather than by industry, so this is a text match on the published text, not a field the corpus stores.

No OHA decision in the corpus names this code.

The market under 541714

Who buys it, who wins it

Prime contract obligations under 541714, FY 2022 to FY 2027 so far, live from USAspending.gov. Companies are summed across their registrations.

Obligations by fiscal year

Obligations by fiscal year could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

Agencies that buy it

The agencies that buy this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

Who wins it

The companies that win this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

What is bought under it

Product and service codes (PSC) on the awards under this industry.

The product and service codes under this industry could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

The largest awards under 541714

Award value to date, from USAspending.gov. Each award opens on USAspending.gov.

The largest awards could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

Open notices under 541714

SAM.govContract Opportunities, refreshed daily. Each notice opens on SAM.gov.

18 open11 due within 30 daysNo set aside 148(a) 3Total Small Business 1

Search every award under 541714

Filter the prime awards by keyword, agency, company, set-aside, place of performance and fiscal-year window, and download the list.

Every open notice, filtered

All open SAM.gov notices under the code by set-aside, notice type and agency, searchable by keyword.

Where you stand under 541714

Your own awards under the code, your size under its standard, and the open notices matched to your company.

Related industries

FAQ

NAICS 541714,
answered.

The size standard, the spending and the buyers under Research and Development in Biotechnology (except Nanobiotechnology), from the figures on this page.

NAICS 541714 is Research and Development in Biotechnology (except Nanobiotechnology) in the 2022 North American Industry Classification System. This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Illustrative Examples: Cloning...

The SBA size standard for NAICS 541714 is 1,000 employees under 13 C.F.R. 121.201. SBA has proposed 2,800 employees in 91 FR 53741; the proposal is not in force until SBA publishes a final rule.

Work the market under 541714

Rank the buyers and the partners under this code, search its awards and notices, and see where your company stands. Monthly Pro starts with a 14-day free trial.

Sources: U.S. Census Bureau, 2022 NAICS; 13 C.F.R. 121.201; USAspending.gov; SAM.gov Contract Opportunities; SBA Office of Hearings and Appeals. Figures refresh daily. A code and a size standard shown here are research, not a size determination or a NAICS code designation, which only SBA and the contracting officer make. A company or agency listed here is not an endorsement.